Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sareum Holdings Plc (SAR.LN)

Sareum Holdings Plc (SAR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,908
  • Shares Outstanding, K 106,839
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,192 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 62.13
Trade SAR.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.760 +116.84%
on 04/08/24
37.800 -32.54%
on 04/24/24
+13.505 (+112.59%)
since 04/05/24
3-Month
10.000 +155.00%
on 03/28/24
45.000 -43.33%
on 02/23/24
-17.000 (-40.00%)
since 02/07/24
52-Week
10.000 +155.00%
on 03/28/24
145.000 -82.41%
on 05/09/23
-117.000 (-82.11%)
since 05/05/23

Most Recent Stories

More News
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update

Sareum Holdings PLC (“Sareum” or the “Company”) Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1...

SAR.LN : 25.900 (+6.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 27.367
2nd Resistance Point 26.633
1st Resistance Point 25.467
Last Price 25.900
1st Support Level 23.567
2nd Support Level 22.833
3rd Support Level 21.667

See More

52-Week High 145.000
Fibonacci 61.8% 93.430
Fibonacci 50% 77.500
Fibonacci 38.2% 61.570
Last Price 25.900
52-Week Low 10.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar